Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
Podcasts are available weekly on the GRACE site
GRACE information is available in many formats - including podcasts!
We have a weekly podcast series mirroring our produced video programs. 52 times per year we offer a weekly podcast with the latest in cancer treatment education. If you are someone who diligently listens to podcasts in the car, in your office, or about the house, download and subscribe to the weekly offering from our programs.
In this podcast series, we work to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates, and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis.
You can access the podcast through your favorite podcast platform (Apple podcasts, Spotify, iHeartRadio, Castbox, Deezer, Podcast Addict, Podchaser, JioSaavn Google podcasts, Spreaker...), or you can see and listen to the newest here on our podcast page.
You can go directly to Spreaker, our podcast host, to listen to the weekly podcasts, and you also can listen via our YouTube channel.
So many options! Don't miss out on great information available in podcast format.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…
That's beautiful Linda. Thank you,